Ergomed (ERGO)

 

Latest News

Appointment of N+1 Singer as joint broker

RNS Number: 7234F Ergomed plc 22 May 2017 PRESS RELEASE FOR IMMEDIATE RELEASE Appointment of N+1 Singer as joint broker London, UK - 22 May 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company'), a company dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, today annou...

Annual Report and Notice of AGM

RNS Number: 0569F Ergomed plc 12 May 2017 Annual Report and Notice of AGM London, UK - 12 May 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company'), a company dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, today announces that it will hold its Annual General Meeting at the off...

Ergomed updates in PharmInvent earn-out

Ergomed has confirmed that the conditions for the issue of 94,618 additional new ordinary shares to former shareholders o...

Issue of Shares to Former PharmInvent Shareholders

RNS Number: 4782E Ergomed plc 08 May 2017 PRESS RELEASE FOR IMMEDIATE RELEASE 8 MAY 2017 Ergomed Issues First Earn-Out Shares to Former Shareholders of PharmInvent London, UK - 8 May 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company'), a company dedicated to the provision of specialised services to the pharmaceutical industry ...

All News

DateHeadlineSource
22-05-17Appointment of N+1 Singer as joint brokerRNS
12-05-17Annual Report and Notice of AGMRNS
08-05-17Ergomed updates in PharmInvent earn-outStockMarketWire
08-05-17Issue of Shares to Former PharmInvent ShareholdersRNS
02-05-17Broker Forecast - Stifel issues a broker note on Ergomed PlcStockMarketWire
02-05-17Broker Forecast - Numis issues a broker note on Ergomed PlcStockMarketWire
02-05-17Co-Development Partner NewsRNS
26-04-1711 shares where positive earnings shocks could trigger ralliesInteractive Investor
13-04-17Board and Management ChangesRNS
04-04-17Director Deals - Ergomed Plc (ERGO)StockMarketWire
04-04-17Director/PDMR ShareholdingRNS
03-04-17Ergomed partner announces successful dataStockMarketWire
03-04-17Partner Asarina Pharma announces successful dataRNS
28-03-17Ergomed revenues up 30%StockMarketWire
28-03-17Ergomed revenues up StockMarketWire
28-03-17Unaudited Preliminary Results for 2016RNS
21-03-17Notice of Preliminary ResultsRNS
20-03-17Ergomed initiates study of PeprostatStockMarketWire
20-03-17Initiates Phase II Study of Topical PeproStatRNS
20-02-17Ergomed notes partner's successful financing roundStockMarketWire
20-02-17Modus Therapeutics Raises SEK 32 MillionRNS
06-02-17Broker Forecast - Numis issues a broker note on Ergomed PlcStockMarketWire
06-02-17Broker Forecast - Stifel issues a broker note on Ergomed PlcStockMarketWire
06-02-17Positive Phase II top-line results of LorediplonRNS
03-02-17Broker Forecast - N+1 Singer issues a broker note on Ergomed PlcStockMarketWire
31-01-17Completion of ZoptrexT Phase 3 Clinical TrialRNS
17-01-1725 momentum stocks for 2017Interactive Investor
17-01-17Ergomed revenues up 26%StockMarketWire
17-01-17Trading StatementRNS
01-12-16Ergomed CFO and general counsel granted optionsStockMarketWire
30-11-16Award of Options by CEO to CFO and General CounselRNS
29-11-16Acquisition of PharmInventRNS
21-11-16Ergomed chairman to step down StockMarketWire
21-11-16Proposed Board ChangesRNS
16-11-16Ergomed expands clinical study with Modus TherapeuticsStockMarketWire
16-11-16Research Update from Modus TherapeuticsRNS
15-11-16Holding(s) in CompanyRNS
07-11-16Broker Forecast - N+1 Singer issues a broker note on Ergomed PlcStockMarketWire
01-11-16Co-Development Agreement with Asarina ABRNS
24-10-16Ergomed notes Dilaforette's plans for IPO StockMarketWire

RSS feeds

  • Editorial news feed for LSE:ERGO Editorial
  • Regulatory news feed for LSE:ERGO Regulatory